The global mycoplasma diagnostics market is witnessing steady expansion, driven by the increasing prevalence of mycoplasmal infections and growing demand for rapid, accurate, and cost-effective diagnostic solutions. Valued at US$ 1.0 billion in 2023, the market is projected to grow at a CAGR of 7.4% from 2024 to 2034, reaching approximately US$ 2.1 billion by the end of 2034. Rising Prevalence...